Breakingviews: Allergan's $41 bln swap

Actavis bought Allergan for $66 bln a few months ago – now it's selling its former business to Teva. Robert Cyran and Richard Beales explain the horse trading.

from Reuters Video: Breakingviews http://ift.tt/1JqaUa7
via IFTTT